Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

L. Chelis · SciRah

Researcher profile · Semantic Scholar

L. Chelis

Share profile

L. Chelis — researcher profile on SciRah

h-index: 11
Works: 27
Citations: 495

Most-cited papers

Transtympanic Injections of N-acetylcysteine for the Prevention of Cisplatin-induced Ototoxicity: A Feasible Method With Promising Efficacy
M. Riga, L. Chelis, S. Kakolyris, S. Papadopoulos +6 more
2013American Journal of Clinical Oncology114 citations
Semantic Scholar
Prognostic role of APC and RASSF1A promoter methylation status in cell free circulating DNA of operable gastric cancer patients.
I. Balgkouranidou, Dimitrios Matthaios, A. Karayiannakis, H. Bolanaki +8 more
2015Mutation research76 citations
Semantic Scholar
Methylation status of the APC and RASSF1A promoter in cell-free circulating DNA and its prognostic role in patients with colorectal cancer.
Dimitrios Matthaios, I. Balgkouranidou, A. Karayiannakis, H. Bolanaki +8 more
2016Oncology Letters61 citations Open access
Semantic Scholar
Reversible Posterior Leukoencephalopathy Syndrome Induced by Pazopanib
L. Chelis, V. Souftas, K. Amarantidis, N. Xenidis +6 more
2012BMC Cancer39 citations Open access
Semantic Scholar
Complete response after sorafenib therapy for hepatocellular carcinoma in an HIV-HBV co infected patient: Possible synergy with HAART ? A case report
L. Chelis, Napoleon Ntinos, V. Souftas, S. Deftereos +4 more
2011Medical Oncology39 citations
Semantic Scholar
Systematic review on T3 laryngeal squamous cell carcinoma; still far from a consensus on the optimal organ preserving treatment.
M. Riga, L. Chelis, V. Danielides, T. Vogiatzaki +2 more
2017European Journal of Surgical Oncology30 citations
Semantic Scholar
Docetaxel plus Oxaliplatin in Combination with Capecitabine as First-Line Treatment for Advanced Gastric Cancer
K. Amarantidis, N. Xenidis, L. Chelis, E. Chamalidou +7 more
2011Oncology24 citations
Semantic Scholar
Hyposmia: an underestimated and frequent adverse effect of chemotherapy
M. Riga, L. Chelis, Theano Papazi, V. Danielides +2 more
2015Supportive Care in Cancer22 citations
Semantic Scholar
Docetaxel plus gemcitabine in combination with capecitabine as treatment for inoperable pancreatic cancer: a phase II study
N. Xenidis, L. Chelis, K. Amarantidis, E. Chamalidou +6 more
2012Cancer Chemotherapy and Pharmacology16 citations
Semantic Scholar
Docetaxel plus cisplatin and bevacizumab for untreated patients with advanced/metastatic non-squamous non-small-cell lung cancer: a multicenter phase II study of the Hellenic Oncology Research Group
N. Kentepozidis, A. Kotsakis, A. Soultati, S. Agelaki +8 more
2013Cancer Chemotherapy and Pharmacology12 citations
Semantic Scholar
Synchronous Breast and Rectal Cancers in a Man
A. Karayiannakis, S. Kakolyris, G. Kouklakis, L. Chelis +3 more
2011Case Reports in Oncology11 citations Open access
Semantic Scholar
Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pre-treated with a non-platinum-based regimen in the first-line setting: a randomized phase II study of the Hellenic Oncology Research Group (HORG)
N. Kentepozidis, P. Economopoulou, C. Christofyllakis, L. Chelis +9 more
2017Clinical and Translational Oncology8 citations
Semantic Scholar
Detection of Hepatocellular Carcinoma in a High-Risk Population by a Mass Spectrometry-Based Test
D. Mahalingam, L. Chelis, Imran Nizamuddin, Sunyoung S. Lee +12 more
2021Cancers7 citations Open access
Semantic Scholar
Biweekly Vinorelbine and Gemcitabine as Second-Line Treatment and Beyond in Non-Small Cell Lung Cancer
L. Chelis, N. Xenidis, K. Amarantidis, P. Prassopoulos +6 more
2010Chemotherapy7 citations
Semantic Scholar
Prognostic significance of different immunohistochemical S100A2 protein expression patterns in patients with operable nonsmall cell lung carcinoma
P. Hountis, P. Foukas, Dimitrios Matthaios, M. Kefala +5 more
2012OncoTargets and Therapy6 citations Open access
Semantic Scholar
Hepatoid Adenocarcinoma of the Gallbladder
A. Karayiannakis, S. Kakolyris, A. Giatromanolaki, N. Courcoutsakis +4 more
2012Journal of Gastrointestinal Cancer6 citations
Semantic Scholar
Bevacizumab plus temsirolimus as second-line treatment for advanced hepatocellular carcinoma (HCC).
L. Chelis, S. Deftereos, N. Xenidis, K. Amarantidis +8 more
20125 citations
Semantic Scholar
A dose escalation study of docetaxel plus capecitabine in combination with oxaliplatin in patients with advanced solid tumors
K. Amarantidis, N. Xenidis, L. Chelis, A. Chiotis +6 more
2010Acta oncologica4 citations Open access
Semantic Scholar
Assesment of SOX-17 gene promoter hypermethylation in hepatocellular carcinoma.
L. Chelis, Ioanna Balgouranidou, T. Koukaki, P. Michailidis +5 more
20133 citations
Semantic Scholar
Abstract 1567: A mass spectrometry based serum test for the detection of hepatocellular carcinoma (HCC) in high risk patients
D. Mahalingam, W. Washburn, G. Halff, L. Chelis +6 more
20152 citations
Semantic Scholar
Management of Early and Metastatic Breast Cancer: A Consensus Statement from Oncologists in Saudi Arabia
Sabah Alaklabi, Sadal Al Refaei, Omalkhair Abualkhair, Atlal M. Abusanad +19 more
2025Oncology and Therapy1 citations Open access
Semantic Scholar
Salvage treatment with irinotecan/cisplatin versus pemetrexed/cisplatin in patients with non-small cell lung cancer pretreated with a non-platinum-based regimen in the first-line setting: A randomized phase II study of the Hellenic Oncology Research Group (HORG).
N. Kentepozidis, P. Economopoulou, C. Christophyllakis, L. Chelis +6 more
20151 citations
Semantic Scholar
Circulating biomarkers of sorafenib efficacy in advanced HCC.
L. Chelis, K. Anagnostopoulos, G. Trypsianis, Eleni Kyrillos Hamalidou +11 more
20131 citations
Semantic Scholar
Abstract 4530: An independent validation of a screening test using mass spectrometry for detection of hepatocellular carcinoma
Sun-Young Lee, K. Attwood, Heinrich Roder, S. Asmellash +8 more
2019Cancer Chemistry0 citations
Semantic Scholar
2388 Serum mass spectrometry analysis in hepatocellular carcinoma (HCC) patients treated with sorafenib (S)
L. Chelis, S. Kakolyris, K. Mimidis, N. Xenidis +3 more
20150 citations
Semantic Scholar
The importance of sequence in rescheduling bevacizumab and chemotherapy administration in the first-line treatment of metastatic colorectal carcinoma (mCRC).
L. Chelis, N. Xenidis, K. Amarantidis, N. Diamantopoulos +10 more
20140 citations
Semantic Scholar
Contents Vol. 80, 2011
Chun-Mei Shi, Bao-Yu Yang, Qiang Chen, Jianwei Yang +158 more
2011Oncology0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

S. Kakolyris×22
Invite
S. Kakolyris — researcher profile on SciRah
N. Xenidis×15
Invite
N. Xenidis — researcher profile on SciRah
P. Michailidis×8
Invite
P. Michailidis — researcher profile on SciRah
E. Chamalidou×7
Invite
E. Chamalidou — researcher profile on SciRah

×7

Invite

K. Amarantidis — researcher profile on SciRah

P. Dimopoulos×6

Invite

P. Dimopoulos — researcher profile on SciRah

A. Karayiannakis×6

Invite

A. Karayiannakis — researcher profile on SciRah

K. Amarantidis×6

Invite

K. Amarantidis — researcher profile on SciRah

S. Deftereos×6

Invite

S. Deftereos — researcher profile on SciRah

Dimitrios Matthaios×5

Invite

Dimitrios Matthaios — researcher profile on SciRah

E. Christakidis×5

Invite

E. Christakidis — researcher profile on SciRah

Invite

H. Bolanaki — researcher profile on SciRah